3.1851
price down icon1.99%   -0.0549
 
loading

Atea Pharmaceuticals Inc Azioni (AVIR) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
49.89%
69.81
46.57 40.78 35.23 41.57
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
49.89%
-69.81
-46.57 -40.78 -35.23 -41.57
Income/Loss From Continuing Operations Before Tax
62.15%
-62.94
-38.81 -32.92 -27.93 -35.27
Income Tax Expense/Benefit
33.81%
0.231
0.349 0.221 0.251 0.197
Income/Loss From Continuing Operations After Tax
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Net Income/Loss
61.29%
-63.17
-39.16 -33.14 -28.18 -35.47
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Diluted Average Shares
544.03K%
83.92
0.0154 83.40 83.40 83.33
Basic Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Diluted Earnings Per Share
59.57%
-0.75
-0.47 -0.40 -0.34 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.36
price down icon 1.39%
$39.11
price up icon 8.69%
$373.11
price up icon 1.50%
$23.09
price up icon 4.62%
biotechnology ONC
$215.13
price down icon 1.63%
$115.49
price down icon 1.75%
Capitalizzazione:     |  Volume (24 ore):